Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors.
Drake KA, Talantov D, Tong GJ, Lin JT, Verheijden S, Katz S, Leung JM, Yuen B, Krishna V, Wu MJ, Sutherland AM, Short SA, Kheradpour P, Mumbach MR, Franz KM, Trifonov V, Lucas MV, Merson J, Kim CC; PRESCO Study Group. Drake KA, et al. Among authors: talantov d. Clin Immunol. 2023 Nov;256:109808. doi: 10.1016/j.clim.2023.109808. Epub 2023 Oct 16. Clin Immunol. 2023. PMID: 37852344 Free article.
Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors.
Drake KA, Talantov D, Tong GJ, Lin JT, Verheijden S, Katz S, Leung JM, Yuen B, Krishna V, Wu MJ, Sutherland A, Short SA, Kheradpour P, Mumbach M, Franz K, Trifonov V, Lucas MV, Merson J, Kim CC; PRESCO Study Group. Drake KA, et al. Among authors: talantov d. bioRxiv [Preprint]. 2023 May 26:2023.05.25.542297. doi: 10.1101/2023.05.25.542297. bioRxiv. 2023. PMID: 37292797 Free PMC article. Updated. Preprint.
Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trial.
Baca-Motes K, Edwards AM, Waalen J, Edmonds S, Mehta RR, Ariniello L, Ebner GS, Talantov D, Fastenau JM, Carter CT, Sarich TC, Felicione E, Topol EJ, Steinhubl SR. Baca-Motes K, et al. Among authors: talantov d. Contemp Clin Trials Commun. 2019 Jan 7;14:100318. doi: 10.1016/j.conctc.2019.100318. eCollection 2019 Jun. Contemp Clin Trials Commun. 2019. PMID: 30656241 Free PMC article.
Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial.
Steinhubl SR, Mehta RR, Ebner GS, Ballesteros MM, Waalen J, Steinberg G, Van Crocker P Jr, Felicione E, Carter CT, Edmonds S, Honcz JP, Miralles GD, Talantov D, Sarich TC, Topol EJ. Steinhubl SR, et al. Among authors: talantov d. Am Heart J. 2016 May;175:77-85. doi: 10.1016/j.ahj.2016.02.011. Epub 2016 Feb 23. Am Heart J. 2016. PMID: 27179726 Free article. Clinical Trial.
Robust multi-tissue gene panel for cancer detection.
Irgon J, Huang CC, Zhang Y, Talantov D, Bhanot G, Szalma S. Irgon J, et al. Among authors: talantov d. BMC Cancer. 2010 Jun 22;10:319. doi: 10.1186/1471-2407-10-319. BMC Cancer. 2010. PMID: 20569444 Free PMC article.
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
Zhang Y, Sieuwerts AM, McGreevy M, Casey G, Cufer T, Paradiso A, Harbeck N, Span PN, Hicks DG, Crowe J, Tubbs RR, Budd GT, Lyons J, Sweep FC, Schmitt M, Schittulli F, Golouh R, Talantov D, Wang Y, Foekens JA. Zhang Y, et al. Among authors: talantov d. Breast Cancer Res Treat. 2009 Jul;116(2):303-9. doi: 10.1007/s10549-008-0183-2. Epub 2008 Sep 23. Breast Cancer Res Treat. 2009. PMID: 18821012 Clinical Trial.
15 results